Algert Global LLC’s Vaxcyte Inc Position
Does Algert Global LLC own Vaxcyte Inc (PCVX)? Yes — 364.0K shares worth $21M (+0.32% of its 13F portfolio) as of Q1 2026, up from 67.4K shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
364.0K
% of Portfolio
+0.32%
Quarters Held
18
currently held
Position History PCVX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 364.0K | $21M | +0.32% |
| Q4 2025 | 67.4K | $3M | +0.05% |
| Q3 2025 | 172.1K | $6M | +0.10% |
| Q2 2025 | 149.6K | $5M | +0.10% |
| Q1 2025 | 56.2K | $2M | +0.05% |
| Q4 2024 | 73.1K | $6M | +0.14% |
| Q3 2024 | 39.3K | $4M | +0.12% |
| Q2 2024 | 34.8K | $3M | +0.09% |
| Q1 2024 | 13.3K | $909,000 | +0.04% |
| Q4 2023 | 14.4K | $904,000 | +0.04% |
| Q3 2023 | 24.8K | $1M | +0.06% |
| Q2 2023 | 22.0K | $1M | +0.05% |
| Q1 2023 | 21.8K | $818,000 | +0.04% |
| Q3 2022 | 45.5K | $1M | +0.07% |
| Q2 2022 | 29.3K | $638,000 | +0.05% |
| Q1 2022 | 9.5K | $229,000 | +0.01% |
| Q4 2021 | 12.8K | $304,000 | +0.04% |
| Q3 2021 | 11.3K | $286,000 | +0.04% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Algert Global LLC’s full portfolio or all institutional holders of PCVX.